Shares of Brown & Brown, Inc. BRO have gained 33.3% in the past year, outperforming its industry, the Finance sector and the Zacks S&P 500 composite’s return. Brown & Brown shares are trading well above the 200-day moving average, indicating a bullish trend. The insurer has a market capitalization of $32.29 billion. The average volume of shares traded in the last three months was 1.79 million. Earnings have grown 21.5% in the past five years, better than the industry average of 15.2%. Brown & Brown's bottom line outpaced estimates in each of the trailing four quarters, the average surprise being 8.18%. BRO Outperforms Industry, Sector & S&P 500 in One YearZacks Investment Research Image Source: Zacks Investment Research BRO Shares are Expensive BRO shares are trading at a premium to the industry. Its price-to-forward 12-months earnings of 26.19X is higher than the industry average of 22.29X. Shares of other insurers like Assurant, Inc. AIZ and CNO Financial Group, Inc. CNO are trading at a multiple higher than the industry average, while shares of Radian Group Inc. RDN are trading at a multiple lower than the industry average.Zacks Investment Research Image Source: Zacks Investment Research BRO’s Encouraging Growth Projection The Zacks Consensus Estimate for Brown & Brown’s 2025 earnings per share indicates a year-over-year increase of 9.1%. The consensus estimate for revenues is pegged at $5.21 billion, implying a year-over-year improvement of 8.3%. The consensus estimate for 2026 earnings per share and revenues indicates an increase of 9.6% and 8.3%, respectively, from the corresponding 2025 estimates. Optimistic Analyst Sentiment on BRO Two of the seven analysts covering the stock have raised estimates for 2025, while one of the six has raised the same for 2026 over the past 30 days. Thus, the Zacks Consensus Estimate for 2024 and 2025 moved 0.2% and 0.2% north, respectively, in the last 30 days. Factors Impacting BRO Commissions and fees, the main component of the top line, benefit from increasing new business, strong retention and continued rate increases for most lines of coverage. The company met its intermediate annual revenue goal of $4 billion, doubling in the last five years. The insurance broker continually makes investments in boosting organic growth and margin expansion. It has an industry-leading adjusted EBITDAC margin. Brown & Brown’s strategic buyouts help it capitalize on growing market opportunities, strengthen its compelling products and service portfolio, expand global reach and accelerate its growth rate. The insurance broker completed 32 acquisitions during the year ended Dec. 31, 2024, and continued to build relationships with many other companies. From 1993 through 2024, the company acquired 674 insurance intermediary operations. The Quintes buyout was the largest transaction in 2024. Banking on operational expertise, BRO boasts a strong liquidity position with an improving leverage ratio. The strength of its operating model and diversity of businesses ensures strong cash conversion. The company effectively deploys cash into acquisitions, capital expenditure and wealth distribution for shareholders via dividend increases. BRO has an impressive dividend history. The strong capital position enables Brown & Brown to distribute wealth to shareholders via dividend increases. To dividend payments, the company has increased dividends for the last 30 years at a five-year (2019-2024) CAGR of 8.7%. Story Continues Conclusion New business, strong retention, rate increases, strategic buyouts and impressive dividend history poise the company well for growth. Favorable growth estimates and positive analyst sentiment are the other positives. A robust capital position over the years reflects its financial flexibility. Thus, despite its premium valuation, this Zacks Rank #2 (Buy) stock remains one of investors’ favorites for addition to their portfolios. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CNO Financial Group, Inc. (CNO):Free Stock Analysis Report Assurant, Inc. (AIZ):Free Stock Analysis Report Radian Group Inc. (RDN):Free Stock Analysis Report Brown & Brown, Inc. (BRO):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
BRO Outperforms Industry, Trades at Premium: How to Play the Stock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...